Joshua Disbrow Insider Profile
4 Followers
Joshua Disbrow, CEO, Director at Aytu BioScience, holds 237.20K shares in Aytu BioScience (Ticker: AYTU), holds 0.00 shares in Zynex (Ticker: ZYXIQ), holds 0.00 shares in Ampio Pharmaceuticals (Ticker: AMPE).
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-4.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joshua Disbrow holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joshua Disbrow
Joshua Disbrow's Trading History
Aytu BioScience
Jul 30, 2026
CEO, Director
Uninformative Buy
―
$491.01K
Zynex
Mar 27, 2026
―
Uninformative Sell
―
$0.00
Ampio Pharmaceuticals
―
COO
―
$0.00
List of latest transactions for each holding click on a transaction to see Joshua Disbrow's performance on stock
You May Also Like
Joshua Disbrow insider profile FAQ
What is the percentage of profitable transactions made by Joshua Disbrow?
The percentage of profitable transactions made by Joshua Disbrow is 43%.
What is the average return per transaction made by Joshua Disbrow?
The average return per transaction made by Joshua Disbrow is -4.40%.
What stocks does Joshua Disbrow hold?
Joshua Disbrow holds: AYTU, ZYXIQ, AMPE stocks.
What was Joshua Disbrow’s latest transaction?
Joshua Disbrow latest transaction was an Uninformative Buy of ―.
What was Joshua Disbrow's most profitable transaction?
Joshua Disbrow’s most profitable transaction was an Informative Buy of AYTU stock on March 3, 2025. The return on the trade was 109.50%.
What is Joshua Disbrow's role in Aytu BioScience?
Joshua Disbrow's role in Aytu BioScience is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.